Comprehensive, long-term evaluation of pancreatic exocrine insufficiency after pancreatoduodenectomy

• Published in: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] Vol. 24; no. 2; pp. 298 - 305
• Main Authors: Powell-Brett, Sarah, Halle-Smith, James M., Hall, Lewis A., Hodson, James, Phillips, Mary E., Roberts, Keith J.
• Format: Journal Article
• Language: English
• Published: Switzerland Elsevier B.V 01.03.2024
• Subjects: 13C breath test; Body Fluids; Breath Tests; Exocrine pancreatic insufficiency; Exocrine Pancreatic Insufficiency - diagnosis; Exocrine Pancreatic Insufficiency - epidemiology; Exocrine Pancreatic Insufficiency - etiology; Humans; Pancreatic function; Pancreaticoduodenectomy - adverse effects; Quality of Life; Pancreatic function; Exocrine pancreatic insufficiency; 13C breath test; C breath test
• ISSN: 1424-3903; 1424-3911
• DOI: 10.1016/j.pan.2023.11.016

Treatment of pancreatic exocrine insufficiency (PEI) following pancreatoduodenectomy (PD) improves quality of life, clinical outcomes, and survival. However, diagnosing PEI following PD is challenging owing to the difficulties with current tests and often non-specific symptoms. This work aims to quantify the true rate of long-term PEI in patients following a PD. Patients underwent a PEI screen approximately one to two years following PD for oncologic indication, including the 13C Mixed triglyceride breath test (13CMTGT), faecal elastase 1 (FE-1) and the PEI Questionnaire (PEI-Q). Four reviewers with expertise in PEI reviewed the results blinded to other decisions to classify PEI status; disagreements were resolved on consensus. 26 patients were recruited. Of those with valid test results, these were indicative of PEI based on pre-specified thresholds for 60 % (15/25) for the 13CMTGT, 82 % (18/22) for FE-1, and 88 % (22/25) for the PEI-Q. After discussion between reviewers, the consensus PEI prevalence was 81 % (95 % CI: 61–93 %; 21/26), with 50 % (N = 13) classified as having severe, 23 % (N = 6) moderate, and 8 % (N = 2) mild PEI. Since no ideal test exists for PEI, this collation of diagnostic modalities and blinded expert review was designed to ascertain the true rate of long-term PEI following PD. This required our cohort to survive a year, travel to hospital, and undergo a period of starvation and PERT hold, and therefore there is likely to be recruitment bias towards fitter, younger patients with less aggressive pathology. Despite this, over 80 % were deemed to have PEI, with over 90 % of these being considered moderate or severe.